1wzy Citations

Crystal structure of human ERK2 complexed with a pyrazolo[3,4-c]pyridazine derivative.

Bioorg Med Chem Lett 16 55-8 (2006)
Cited: 23 times
EuropePMC logo PMID: 16242327

Abstract

A series of pyrazolopyridazine compounds were briefly investigated as ERK2 inhibitors. The crystal structure of ERK2 complexed with an allyl derivative was determined. The compound induces structural change including movement of the glycine-rich loop and peptide flip between Met108-Glu109. As a result, the newly formed subsite can recognize small hydrophobic substituents but not hydrophilic ones.

Articles - 1wzy mentioned but not cited (7)

  1. A chemical genetic approach demonstrates that MPK3/MPK6 activation and NADPH oxidase-mediated oxidative burst are two independent signaling events in plant immunity. Xu J, Xie J, Yan C, Zou X, Ren D, Zhang S. Plant J 77 222-234 (2014)
  2. Serotyping Streptococcus pneumoniae by multiplex PCR. Brito DA, Ramirez M, de Lencastre H. J Clin Microbiol 41 2378-2384 (2003)
  3. Using a Genetically Encoded Sensor to Identify Inhibitors of Toxoplasma gondii Ca2+ Signaling. Sidik SM, Hortua Triana MA, Paul AS, El Bakkouri M, Hackett CG, Tran F, Westwood NJ, Hui R, Zuercher WJ, Duraisingh MT, Moreno SN, Lourido S. J Biol Chem 291 9566-9580 (2016)
  4. The structural pathway of interleukin 1 (IL-1) initiated signaling reveals mechanisms of oncogenic mutations and SNPs in inflammation and cancer. Acuner Ozbabacan SE, Gursoy A, Nussinov R, Keskin O. PLoS Comput Biol 10 e1003470 (2014)
  5. Utilizing network pharmacology and molecular docking to explore the underlying mechanism of Guizhi Fuling Wan in treating endometriosis. Wang H, Zhou G, Zhuang M, Wang W, Fu X. PeerJ 9 e11087 (2021)
  6. Target Identification of 22-(4-Pyridinecarbonyl) Jorunnamycin A, a Tetrahydroisoquinoline Derivative from the Sponge Xestospongia sp., in Mediating Non-Small-Cell Lung Cancer Cell Apoptosis. Iksen I, Sinsook S, Wattanathamsan O, Buaban K, Chamni S, Pongrakhananon V. Molecules 27 8948 (2022)
  7. Light-Mediated Transformation of Renieramycins and Semisynthesis of 4'-Pyridinecarbonyl-Substituted Renieramycin-Type Derivatives as Potential Cytotoxic Agents against Non-Small-Cell Lung Cancer Cells. Sinsook S, Buaban K, Iksen I, Petsri K, Innets B, Chansriniyom C, Suwanborirux K, Yokoya M, Saito N, Pongrakhananon V, Chanvorachote P, Chamni S. Mar Drugs 21 400 (2023)


Reviews citing this publication (1)

  1. Untangling tau hyperphosphorylation in drug design for neurodegenerative diseases. Mazanetz MP, Fischer PM. Nat Rev Drug Discov 6 464-479 (2007)

Articles citing this publication (15)